Regentis Biomaterials Ltd. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2026-06-25: Federal exemption Rule 506(c); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2026-06-17; Total offering amount $6,500,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2026-06-25 | Rule 506(c) | Equity; OptionToAcquire; SecurityToBeAcquired | 2026-06-17 | $6,500,000 | $6,500,000 | $0 | 22 |